International Stem Cell Corporation (ISCO)
OTCMKTS · Delayed Price · Currency is USD
0.4980
+0.0480 (10.67%)
At close: Aug 21, 2026
International Stem Cell Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9.51 | 9.1 | 9.09 | 7.79 | 8.18 | 7.18 | |
Revenue Growth | 3.40% | 0.17% | 16.64% | -4.78% | 13.99% | 0.67% |
Cost of Revenue | 4.29 | 4.03 | 3.76 | 3.18 | 3.27 | 2.94 |
Gross Profit | 5.23 | 5.07 | 5.32 | 4.61 | 4.91 | 4.24 |
Selling, General & Admin | 5.51 | 5.24 | 5.17 | 5.2 | 5.05 | 5.9 |
Research & Development | 0.06 | 0.09 | 0.22 | 0.07 | 0.04 | 0.01 |
Operating Expenses | 5.56 | 5.33 | 5.39 | 5.27 | 5.09 | 5.91 |
Operating Income | -0.33 | -0.27 | -0.07 | -0.66 | -0.18 | -1.67 |
Interest Expense | -0.14 | -0.15 | -0.15 | -0.14 | -0.14 | -0.13 |
Other Non Operating Income (Expenses) | 0 | - | 0 | 0.01 | -0.01 | 0.01 |
EBT Excluding Unusual Items | -0.47 | -0.42 | -0.21 | -0.79 | -0.33 | -1.79 |
Asset Writedown | -0.11 | - | - | - | - | -0.25 |
Other Unusual Items | - | - | - | 0.66 | - | 1.14 |
Pretax Income | -0.58 | -0.42 | -0.21 | -0.13 | -0.33 | -0.9 |
Net Income | -0.58 | -0.42 | -0.21 | -0.13 | -0.33 | -0.9 |
Net Income to Common | -0.58 | -0.42 | -0.21 | -0.13 | -0.33 | -0.9 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | 8 |
Shares Change | - | - | - | - | 2.19% | 3.90% |
EPS (Basic) | -0.07 | -0.05 | -0.03 | -0.02 | -0.04 | -0.11 |
EPS (Diluted) | -0.07 | -0.05 | -0.03 | -0.02 | -0.04 | -0.11 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.33 | -0.04 | -0.15 | 0.85 | 0.33 | -1.32 |
Free Cash Flow Per Share | 0.04 | -0.00 | -0.02 | 0.11 | 0.04 | -0.17 |
Gross Margin | 54.96% | 55.68% | 58.57% | 59.16% | 60.04% | 59.10% |
Operating Margin | -3.50% | -2.93% | -0.75% | -8.51% | -2.24% | -23.29% |
Profit Margin | -6.12% | -4.59% | -2.30% | -1.68% | -4.05% | -12.53% |
Free Cash Flow Margin | 3.50% | -0.39% | -1.68% | 10.90% | 4.05% | -18.39% |
EBITDA | -0.16 | -0.05 | 0.14 | -0.47 | 0.04 | -1.41 |
EBITDA Margin | -1.70% | -0.53% | 1.52% | -6.02% | 0.43% | -19.63% |
D&A For EBITDA | 0.17 | 0.22 | 0.21 | 0.19 | 0.22 | 0.26 |
EBIT | -0.33 | -0.27 | -0.07 | -0.66 | -0.18 | -1.67 |
EBIT Margin | -3.50% | -2.93% | -0.75% | -8.51% | -2.24% | -23.29% |
Advertising Expenses | - | 0.1 | 0.18 | 0.2 | 0.22 | 0.17 |